Plague or anthrax on the subway? Think again, says now-corrected study

Cell SystemsAuthors of a widely covered study that documented traces of plague and anthrax on surfaces across New York City have revised the paper after public health officials challenged their interpretations of the data.

It’s hard to overestimate the attention these findings received when first published.

Bubonic plague found in NYC subway,” wrote The Daily Beast.

Your subway seat mate: Bubonic plague, anthrax, & mysterious DNA,” said Yahoo!

NY subway has bubonic plague,” declared Newser.

Not so fast. In an erratum published July 29, the authors write: Continue reading Plague or anthrax on the subway? Think again, says now-corrected study

Voinnet notches second retraction, two more corrections

PNASOlivier Voinnet — a plant researcher who was recently suspended for two years from the Centre national de la recherche scientifique (CNRS) after an investigation by ETH Zurich and CNRS found evidence of misconduct — has issued his second retraction and two more corrections.

PNAS posted the retraction earlier this week for a 2006 article after an inspection of the raw data revealed “errors” in study images. Authors confirmed the issues in some figures and revealed “additional mounting mistakes” in others.

Voinnet has promised to issue retractions and corrections for every study that requires them. These latest notices bring our tally up to nine corrections, two retractions and one Expression of Concern.

Continue reading Voinnet notches second retraction, two more corrections

“To our horror”: Widely reported study suggesting divorce is more likely when wives fall ill gets axed

home_coverA widely reported finding that the risk of divorce increases when wives fall ill — but not when men do — is invalid, thanks to a short string of mistaken coding that negates the original conclusions, published in the March issue of the Journal of Health and Social Behavior.

The paper, “In Sickness and in Health? Physical Illness as a Risk Factor for Marital Dissolution in Later Life,” garnered coverage in many news outlets, including The Washington Post, New York magazine’s The Science of Us blog, The Huffington Post, and the UK’s Daily Mail 

But an error in a single line of the coding that analyzed the data means the conclusions in the paper — and all the news stories about those conclusions — are “more nuanced,” according to first author Amelia Karraker, an assistant professor at Iowa State University.

Karraker — who seems to be handling the case quickly and responsibly —  emailed us how she realized the error:

Continue reading “To our horror”: Widely reported study suggesting divorce is more likely when wives fall ill gets axed

JAMA issues mega-correction for data breach letter due to “wording and data errors”

s_cover_jcv062315A JAMA letter published in April on data breaches accidentally included some data that shouldn’t have been published, either — specifically, “wording and data errors” that affected five sentences and more than 10 entries in a table. One result — a reported increase in breaches over time — also went from statistically significant to “borderline” significant, according to the first author. (So yeah, this post earns our “mega correction” category.)

According to an author, an “older version” of a table made it into the letter, “Data Breaches of Protected Health Information in the United States,” which was corrected in the journal’s June 23/30 issue.

The letter and table in question detail 949 breaches of “unencrypted protected health information.”  The letter says the number of breaches has increased from 2010 to 2013; the original article claimed that the P value on that increase was <.001, but the correction says it’s really 0.07. The original says 29.1 million personal records were affected in those breaches; the real number is 29.0. And so on.

Continue reading JAMA issues mega-correction for data breach letter due to “wording and data errors”

Misidentified genetic sequence causes retraction of pathogen paper one month after publication

Genome Announcements

The author of an article mapping the genome of an infectious bacterium is pulling the paper because — well, it wasn’t the bacterium she thought it was.

Study author Celia Abolnik is retracting her paper in Genome Announcements because it didn’t actually map out the DNA of Mycoplasma meleagridis, a bacterium that typically infects turkeys but has recently been found in chickens.

The trouble was, the sequence for Mycoplasma meleagridis in the National Institute of Health’s DNA database, Genbank, was actually a different variety of bacteria — Mycoplasma gallinaceum, another scourge of poultry.

Here’s the notice for “Complete Genome Sequence of Mycoplasma meleagridis, a Possible Emerging Pathogen in Chickens:”

Continue reading Misidentified genetic sequence causes retraction of pathogen paper one month after publication

He shoots, he…misses! Soccer injury paper gets red card for data errors

jsmsThe authors of a 2014 paper on soccer injuries have forfeited their publication after revealing that the foundation of the work was based on faulty data. (Look, we could have written about letting air out of balls, yadda yadda, but the Super Bowl has come and gone.)

The article, which appeared in the Journal of Science and Medicine in Sport, was written by a group in Denmark and Qatar led by Cristiano Eirale, a sports medicine researcher at the Aspetar-Qatar Orthopedic and Sports Medicine Hospital, in Doha. It showed goalies had a lower rate of injuries during training than field players.

Trouble was, someone called a foul.

Continue reading He shoots, he…misses! Soccer injury paper gets red card for data errors

Structure error sinks NIH-MIT-SNU peptide paper

CHBIOL_21_9.c1.inddA mistake in structure identification has sunk a paper by researchers at the NIH, MIT, and Seoul National University in the Cell Press journal Chemistry and Biology.

Here’s the notice for “Peptide-Based Inhibitors of Plk1 Polo-box Domain Containing Mono-anionic Phosphothreonine Esters and Their Pivaloyloxymethyl Prodrugs”: Continue reading Structure error sinks NIH-MIT-SNU peptide paper

Cell line switch sinks PLoS ONE cancer paper

plosWe’ve written before about how common cell line mix ups are in cancer research; according to a 2012 Wall Street Journal article (paywalled), between a fifth and a third of cancer cell lines tested by suspicious researchers turned out to be misidentified.

Obviously, mistakenly studying the wrong kind of cancer is a waste of precious resources, both time and money. And it’s clear the problem hasn’t gone away. PLoS ONE just retracted a cancer paper originally published in December 2012 for studying two cell lines that had been contaminated by other cell types.

Here’s the notice for “Epithelial Mesenchymal Transition Is Required for Acquisition of Anoikis Resistance and Metastatic Potential in Adenoid Cystic Carcinoma”:
Continue reading Cell line switch sinks PLoS ONE cancer paper

Doing the right thing: Particle physicists pull paper after equation collides with the truth

physicalreviewlettersThree physicists at Imperial College London have retracted a paper on Coulomb collisions, a kind of fender bender between two charged particles, after realizing their equations were written wrong.

The mistake resulted in an erroneous conclusion about the strength of the collisions.

Here’s the notice for “Effects of Large-Angle Coulomb Collisions on Inertial Confinement Fusion Plasmas”: Continue reading Doing the right thing: Particle physicists pull paper after equation collides with the truth

Double dipping on trial data topples 17-year-old macular degeneration article

redjournalThe authors of a 1997 paper on macular degeneration have lost the article after readers noticed uncanny similarities with a 1996 publication from several of the same authors.

The retracted article, “Radiation therapy for macular degeneration: Technical considerations and preliminary results,” appeared in the International Journal of Radiation Oncology*Biology*Physics — otherwise known as the “Red Journal.” The first author, Luther W. Brady, is a leading U.S. oncologist.

According to the retraction notice: Continue reading Double dipping on trial data topples 17-year-old macular degeneration article